Sanofi India Limited

NSE SANOFI.NS

Sanofi India Limited EBITDA Margin for the year ending December 31, 2023: 31.10%

Sanofi India Limited EBITDA Margin is 31.10% for the year ending December 31, 2023, a -5.10% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Sanofi India Limited EBITDA Margin for the year ending December 31, 2022 was 32.77%, a -27.72% change year over year.
Sanofi India Limited EBITDA Margin for the year ending December 31, 2021 was 45.34%, a 70.89% change year over year.
Sanofi India Limited EBITDA Margin for the year ending December 31, 2020 was 26.53%, a 14.27% change year over year.
Sanofi India Limited EBITDA Margin for the year ending December 31, 2019 was 23.22%, a -10.63% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

NSE: SANOFI.NS

Sanofi India Limited

CEO	Mr. Rodolfo Hrosz
IPO Date	July 1, 2002
Location	India
Headquarters	Sanofi House
Employees	2,174
Sector	Healthcare
Industries Pharmaceuticals Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care Tobacco

Description

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

Key trends

Past 5 years